SQZ Biotechnologies's market cap is currently $884.73K. The company's EPS TTM is $-2.429; its P/E ratio is ―; SQZ Biotechnologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 21.48M	$ 27.10M	$ 21.00M	$ 20.11M	$ 12.67M
Gross Profit	$ 9.79M	$ 16.07M	$ 21.00M	$ 20.11M	$ 12.67M
Operating Income	$ -75.83M	$ -68.77M	$ -51.06M	$ -34.27M	$ -20.40M
EBITDA	$ -64.14M	$ -57.74M	$ -40.12M	$ -29.91M	$ -18.18M
Net Income	$ -79.46M	$ -68.74M	$ -50.52M	$ -32.20M	$ -20.23M
Balance Sheet
Cash & Short-Term Investments	$ 63.71M	$ 143.51M	$ 170.36M	$ 98.28M	$ 106.91M
Total Assets	$ 107.19M	$ 226.15M	$ 231.14M	$ 152.35M	$ 115.55M
Total Debt	$ 27.47M	$ 69.69M	$ 47.09M	$ 42.33M	$ 0.00
Net Debt	$ -36.24M	$ -73.82M	$ -123.26M	$ 3.08M	$ -59.57M
Total Liabilities	$ 50.04M	$ 102.18M	$ 103.94M	$ 93.76M	$ 52.69M
Stockholders' Equity	$ 57.15M	$ 123.98M	$ 127.20M	$ 58.59M	$ 62.86M
Cash Flow
Free Cash Flow	$ -84.07M	$ -82.75M	$ -44.33M	$ -35.66M	$ 19.79M
Operating Cash Flow	$ -83.55M	$ -82.14M	$ -43.15M	$ -33.49M	$ 21.10M
Investing Cash Flow	$ -488.00K	$ -613.00K	$ 57.82M	$ -12.85M	$ -36.96M
Financing Cash Flow	$ 4.23M	$ 55.91M	$ 116.42M	$ 26.04M	$ 68.12M

Currency in USD

SQZ Biotechnologies Earnings and Revenue History

Income Statement >

SQZ Biotechnologies Debt to Assets

Balance Sheet >

SQZ Biotechnologies Cash Flow

Cash Flow >

SQZ Biotechnologies Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing